Pascal and Francis Bibliographic Databases



Selection :

Permanent link

Raloxifene and selective cell cycle specific agents : A case for the inclusion of raloxifene in current breast cancer treatment therapies

FRYAR-TITA, Elizabeth B1 ; DAS, Jharna R2 ; DAVIS, J. H3 ; DESOTO, J. A4 ; GREEN, Sidney2 ; SOUTHERLAND, William M5 ; BOWEN, Donnell2
[1] Department of Environmental Sciences and Engineering, The University of North Carolina at Chapel Hill, Chapel Hill, NC, United States
[2] Department of Pharmacology, College of Medicine, Howard University, Washington, DC, United States
[3] Pharmacy School, Hampton University, Hampton VA, United States
[4] National Institutes of Health, NIDDK, Bethesda MD, United States
[5] Department of Biochemistry, College of Medicine, Howard University, Washington, DC, United States

Anticancer research. 2007, Vol 27, Num 3B, pp 1393-1399, 7 p ; ref : 17 ref

Scientific domain
Medical oncology
International Institute of Anticancer Research, Attiki
Publication country
Document type
Author keyword
5-fluorouracil Selective estrogen receptor modulator breast cancer osteoporosis raloxifene trimetrexate
Keyword (fr)
Anticancéreux Cancérologie Cycle cellulaire Fluorouracil Ostéoporose Raloxifène Traitement Trimétrexate Cancer du sein Modulateur sélectif récepteur oestrogène Agoniste antagoniste Antifolate Antihormone Antimétabolite Antioestrogène Benzothiophène dérivé Composé non stéroïde Dihydrofolate reductase Enzyme Fluoropyrimidine dérivé Glande mammaire pathologie Inhibiteur enzyme Methyltransferases Oxidoreductases Pyrimidine dérivé Récepteur oestrogène Système ostéoarticulaire pathologie Thymidylate synthase Transferases Tumeur maligne
Keyword (en)
Antineoplastic agent Cancerology Cell cycle Fluorouracil Osteoporosis Raloxifene Treatment Trimetrexate Breast cancer Selective estrogen receptor modulator Agonist antagonist Antifolate Antihormone Antimetabolic Antiestrogen Benzothiophene derivatives Non steroid compound Dihydrofolate reductase Enzyme Fluoropyrimidine derivatives Mammary gland diseases Enzyme inhibitor Methyltransferases Oxidoreductases Pyrimidine derivatives Estrogen receptor Diseases of the osteoarticular system Thymidylate synthase Transferases Malignant tumor
Keyword (es)
Anticanceroso Cancerología Ciclo celular Fluorouracilo Osteoporosis Raloxifeno Tratamiento Trimetrexato Cáncer de pecho Agonista antagonista Antifolato Antihormona Antimetabólito Antiestrógeno Benzotiofeno derivado Compuesto no esteroide Dihydrofolate reductase Enzima Fluoropirimidina derivado Glándula mamaria patología Inhibidor enzima Methyltransferases Oxidoreductases Pirimidina derivado Receptor estrógeno Sistema osteoarticular patología Thymidylate synthase Transferases Tumor maligno
002 Biological and medical sciences / 002B Medical sciences / 002B04 Tumors

002 Biological and medical sciences / 002B Medical sciences / 002B20 Gynecology. Andrology. Obstetrics / 002B20E Mammary gland diseases / 002B20E02 Tumors

Gynecology. Andrology. Obstetrics Tumours
INIST identifier

Sauf mention contraire ci-dessus, le contenu de cette notice bibliographique peut être utilisé dans le cadre d’une licence CC BY 4.0 Inist-CNRS / Unless otherwise stated above, the content of this bibliographic record may be used under a CC BY 4.0 licence by Inist-CNRS / A menos que se haya señalado antes, el contenido de este registro bibliográfico puede ser utilizado al amparo de una licencia CC BY 4.0 Inist-CNRS

Searching the Web